Zeldox 40 mg hard capsules

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

Zeldox 40 mg hard capsules

ziprasidone

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

• Keep this leaflet. You may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only and must not be given to other people, even if they have the same symptoms as you. It may harm them.
• If you experience any side effects, talk to your doctor or pharmacist, even if it is a side effect not listed in this leaflet. See section 4.

Contents of the leaflet

1. What Zeldox capsules are and what they are used for
2. What you need to know before taking Zeldox capsules
3. How to take Zeldox capsules
4. Possible side effects
5. How to store Zeldox capsules
6. Contents of the pack and other information

1. What Zeldox capsules are and what they are used for

Zeldox capsules is a medicine belonging to a group of medicines called antipsychotics.

Zeldox capsules are indicated for the treatment of schizophrenia in adults, a mental illness characterized by the presence of one or more of the following symptoms: hearing, seeing, or feeling things that do not exist, believing things that are not true, unusual suspiciousness, social withdrawal and difficulty forming social relationships, nervousness, depression, or anxiety.

In addition, Zeldox capsules are used in adults and in children and adolescents aged 10 to 17 years for the treatment of moderate severity manic symptoms in bipolar disorder, which is a mental illness characterized by alternating phases of euphoric (mania) or depressed mood. During manic episodes, the most characteristic symptoms include: euphoric behavior, exaggerated self-esteem, increased energy, reduced need for sleep, lack of concentration, hyperactivity, and repetition of risky behaviors.

2. What you need to know before starting to take Zeldox capsules

Do not take Zeldox capsules

• If you are allergic to ziprasidone or to any of the other ingredients of this medicine (listed in section 6). An allergic reaction may be recognized by the appearance of skin rash, itching, swelling of the face or lips, or difficulty breathing.
• If you have or have had heart disease or have recently had a heart attack.
• If you are taking medicines for heart rhythm disorders (arrhythmias) or medicines that can affect heart rhythm.

See section "Use of Zeldox capsules with other medicines" below.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to take Zeldox capsules

• if you or someone in your family has a history of blood clots, as this type of medicine has been associated with blood clot formation

• if you have liver problems

• if you have or have had seizures or epilepsy

• if you are over 65 years of age and have dementia and are at high risk of stroke (cerebrovascular accident)

• if you have a significant decrease in resting heart rate, and/or you know you may have low levels of blood salts as a result of prolonged severe diarrhoea and vomiting or due to the use of diuretics (which promote elimination of excess fluid)

• if you experience symptoms such as rapid or irregular heartbeat, fainting, syncope, or dizziness upon standing, as these may indicate abnormal heart rhythm.

Contact your doctor immediately if you experience any of the following symptoms:

• Severe skin reactions such as rash with blisters, which may be accompanied by mouth ulcers, skin peeling, fever, and skin lesions resembling target-shaped spots, possibly indicating Stevens-Johnson syndrome. These skin reactions could be potentially life-threatening.
• Zeldox capsules may cause drowsiness, low blood pressure upon standing, dizziness, and gait disturbances, which may lead to falls. Caution is advised, especially if you are elderly or have any physical weakness.

Inform your doctor that you are taking Zeldox capsules before undergoing any diagnostic tests (including blood and urine tests, liver function tests, heart rhythm monitoring, etc.), as this medication may alter test results.

Children and adolescents

The safety and efficacy of ziprasidone in the treatment of schizophrenia in children and adolescents have not been established.

Use of Zeldox capsules with other medicines

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines, including those obtained without a prescription.

Do not take Zeldox capsules if you are taking medicines for heart rhythm disorders or medicines that may affect heart rhythm, such as:

Class IA and III antiarrhythmics, arsenic trioxide, halofantrine, levomethadyl acetate, mesoridazine, thioridazine, pimozide, sparfloxacin, gatifloxacin, moxifloxacin, dolasetron mesylate, mefloquine, sertindole, or cisapride. These medicines may alter heart rhythm by prolonging the QT interval. If you have further questions about this effect, consult your doctor.

Consult your doctor or pharmacist before starting to take Zeldox capsules.

Inform your doctor or pharmacist if you are taking or have recently taken medicines for:

• bacterial infections; these medicines are known as antibiotics; for example macrolide antibiotics or rifampicin;
• mood changes (from depressive mood to euphoria), agitation, and irritability; these medicines are known as mood stabilizers, for example lithium, carbamazepine, valproate;
• depression, including some serotonergic medicines, for example SSRIs (Selective Serotonin Reuptake Inhibitors) such as fluoxetine, paroxetine, sertraline; or herbal or natural remedies containing St. John's Wort;
• epilepsy, for example phenytoin, phenobarbital, carbamazepine, ethosuximide;
• Parkinson's disease, for example levodopa, bromocriptine, ropinirole, pramipexole;
• or if you are taking or have recently taken the following medicines: verapamil, quinidine, itraconazole, or ritonavir;

See section “Do not take Zeldox capsules” above.

Taking Zeldox with food and drinks

ZELDOX CAPSULES SHOULD BE TAKEN DURING MAIN MEALS.

You should not consume alcoholic beverages during treatment with Zeldox capsules, as this may increase the risk of adverse effects.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before taking this medicine.

Pregnancy

You should not take Zeldox capsules during pregnancy unless your doctor specifically instructs you to do so, as there is a risk that this medicine may harm your baby. Always use an appropriate contraceptive method.

The following symptoms may occur in newborn babies whose mothers have taken Zeldox during the third trimester (last three months of pregnancy): tremors, muscle stiffness and/or weakness, sleepiness, agitation, breathing difficulties, and feeding problems. If your baby develops any of these symptoms, contact your doctor.

Breastfeeding

You should not breastfeed while being treated with Zeldox capsules. This is because small amounts of the medicine may pass into breast milk.

Contraception

If you are able to become pregnant, you should use an appropriate contraceptive method while taking this medicine.

Driving and use of machines

Taking Zeldox capsules may cause drowsiness. If you experience this symptom, refrain from driving or operating heavy or dangerous machinery until the symptom resolves.

Zeldox capsules contain lactose

Zeldox capsules contain lactose. If your doctor has informed you that you have an intolerance to certain sugars, consult with him before taking this medicine.

Zeldox capsules contain sodium

Zeldox capsules contain less than 23 mg of sodium (1 mmol) per capsule; therefore, it is essentially “sodium-free”.

3. How to take Zeldox capsules

Follow exactly the instructions for use of this medicine given by your doctor. If in doubt, consult your doctor or pharmacist again.

The capsules should be taken with food and swallowed whole without chewing, crushing, or opening them beforehand. It is important not to chew, crush, or open the capsules, as this may affect the site in the intestine where the medicine is absorbed.

Zeldox capsules should be taken twice daily: one capsule in the morning with a substantial breakfast and one in the evening with dinner (see blister pack). Try to take this medicine at the same time each day.

Adults

The recommended dose is 40 to 80 mg of ziprasidone twice daily with food.

For long-term treatment, your doctor may adjust the dose. It is recommended not to exceed the maximum daily dose of 160 mg.

Children and adolescents with bipolar mania

The recommended starting dose is 20 mg once daily with food. Your doctor will then determine your optimal dose. It is recommended not to exceed the maximum dose established by weight range: 160 mg daily for children weighing 45 kg or more, and 80 mg daily for children weighing less than 45 kg.

The safety and efficacy of ziprasidone in the treatment of schizophrenia in children and adolescents has not been established.

Patients over 65 years of age

If you are over 65 years old, your doctor will decide the appropriate dose for you. The dose for patients over 65 may be lower than that used in younger individuals. Your doctor will inform you of the appropriate dose.

Patients with liver problems

If you have liver problems, you may need to take a lower dose of Zeldox capsules. Your doctor will tell you the correct dose for you.

If you take more Zeldox capsules than you should

Contact your doctor immediately or go to the nearest hospital emergency department. Contact your doctor, pharmacist, or call the Toxicology Information Service at 915620420, indicating the medicine and the amount taken. It is recommended to bring the medicine packaging and leaflet to the healthcare professional.

If you have taken too much Zeldox capsules, symptoms such as drowsiness, tremor, seizures, and involuntary movements of the head and neck may occur.

If you forget to take Zeldox:

It is important to take Zeldox capsules at the same time each day. If you forget to take a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and take the next one at the regular time.

Do not take a double dose to make up for forgotten doses.

If you stop taking Zeldox capsules

Your doctor will tell you how long you should take Zeldox capsules. Do not stop taking this medicine unless instructed by your doctor.

It is important to continue treatment even if you feel better. If you stop treatment too early, symptoms may return.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can produce adverse effects, although not everyone will experience them. It may often be difficult to distinguish the symptoms of your illness from adverse effects.

STOP taking Zeldox capsules and contact your doctor immediately if you experience any of the following serious adverse effects:

Common adverse effects (may affect up to 1 in 10 patients):

• Involuntary/unusual movements, especially of your face or tongue.

Uncommon adverse effects (may affect up to 1 in 100 patients):

• Rapid or irregular heartbeat, dizziness upon standing, which may indicate abnormal heart function. These could be symptoms of a condition known as postural hypotension.

• Rare adverse effects (may affect up to 1 in 1,000 patients): Swelling of the face, lips, tongue, or throat, and difficulty swallowing or breathing, urticaria. These could be symptoms of a severe allergic reaction such as angioedema.

• Fever, rapid breathing, sweating, muscle stiffness, tremor, difficulty swallowing, and reduced consciousness—these could be symptoms of a disease known as neuroleptic malignant syndrome.

• Skin reactions, especially rash, fever, and swollen lymph nodes, which could be symptoms of a condition called drug reaction with eosinophilia and systemic symptoms (DRESS). These reactions could be potentially fatal.

• Confusion, agitation, fever, sweating, lack of coordination in muscle movements, muscle spasms. These could be symptoms of a disease known as serotonin syndrome.

• Rapid or irregular heartbeat, fainting—these may be symptoms of a potentially life-threatening condition known as Torsades de Pointes.

• Abnormally prolonged and painful erection of the penis.

You may experience some of the adverse effects listed below. These potential adverse effects are generally mild to moderate in nature and may resolve over time. However, if the adverse effect is severe or persistent, contact your doctor.

Very common adverse effects (may affect more than 1 in 10 patients):

• Difficulty sleeping
• Drowsiness or excessive daytime sleepiness
• Headache

Common adverse effects (may affect up to 1 in 10 patients):

• Runny nose
• Elevated mood, strange thought patterns, hyperactivity, feeling restless or anxious
• Restlessness
• Abnormal movements including involuntary movements, muscle rigidity, slow movements
• Dizziness
• Sedation
• Blurred or impaired vision
• High blood pressure
• Constipation, diarrhea, nausea, vomiting, and indigestion, dry mouth, increased salivation
• Rash
• Male sexual problems
• Fever
• Pain
• Weight loss or weight gain
• Exhaustion
• General feeling of being unwell

Uncommon adverse effects (may affect up to 1 in 100 patients):

• Elevated levels of prolactin in the blood
• Increased appetite
• Panic attacks
• Feelings of nervousness or depression
• Decreased sex drive
• Loss of consciousness
• Difficulty controlling movements/involuntary movements
• Restless legs
• Sensation of throat tightness, nightmares
• Seizures, involuntary eye movements to a fixed position, clumsiness, speech disturbance, numbness, tingling sensation, decreased ability to concentrate, drooling
• Palpitations, difficulty breathing
• Light sensitivity, dry eyes, ringing in the ears, ear pain
• Sore throat, flatulence, stomach discomfort
• Itchy skin rash, acne
• Muscle cramps, joint stiffness or swelling
• Thirst, chest discomfort, changes in walking pattern
• Acid reflux, stomach pain
• Hair loss
• Unusual head position
• Urinary incontinence, pain or difficulty urinating
• Abnormal production of breast milk
• Enlargement of male breasts
• Absence of menstruation
• Abnormal blood tests and heart tests
• Abnormal liver function tests
• Dizziness
• General weakness and fatigue

Rare adverse effects (may affect up to 1 in 1,000 patients):

• Decreased concentration of calcium in the blood
• Slowed thinking, lack of emotional expressiveness
• Facial paralysis
• Paralysis
• Partial or complete vision loss in one eye, itchy eyes
• Difficulty speaking, hiccups
• Soft stools
• Skin irritation
• Inability to open the mouth
• Difficulty emptying the bladder
• Withdrawal syndrome in newborns
• Reduced orgasm
• Feeling of warmth
• Increase or decrease in white blood cells (in blood tests)
• Raised, red, inflamed areas of skin covered with white scales, known as psoriasis

Frequency not known (cannot be estimated from available data):

• In elderly patients with dementia, a small increase in the number of deaths has been observed in patients treated with antipsychotics compared to those not taking antipsychotics.
• Blood clots in the veins, especially in the legs (symptoms may include swelling, pain, and redness in the leg), which may travel through blood vessels to the lungs, causing chest pain and difficulty breathing. If you notice any of these symptoms, consult your doctor immediately.

Additional adverse effects in children and adolescents

In clinical trials with children and adolescents, adverse effects were generally similar to those in adults (see above), except that sedation and drowsiness were more frequent in children. The most common adverse effects in children and adolescents were sedation, drowsiness, headache, exhaustion, nausea, dizziness, vomiting, decreased appetite, and movement disorders.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if they are possible adverse effects not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Zeldox capsules

Keep this medicine out of the sight and reach of children.

Do not store above 30°C.

Do not use this medicine after the expiry date stated on the container. The expiry date refers to the last day of the month indicated.

Medicines must not be disposed of via wastewater or household waste. Dispose of empty containers and unused medicines at the SIGRE collection point at your pharmacy. Ask your pharmacist how to properly dispose of containers and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Zeldox 40 mg hard capsules

• The active substance is ziprasidone. Each hard capsule contains 40 mg of ziprasidone in the form of ziprasidone hydrochloride monohydrate.
• The other components are: lactose monohydrate (see section 2), pregelatinized corn starch, magnesium stearate, gelatin, titanium dioxide (E171), sodium lauryl sulfate (sodium dodecyl sulfate) (see section 2), indigotine (E132), shellac, propylene glycol (E1520), ammonium hydroxide (E527), potassium hydroxide (E525), and black iron oxide (E172).

Appearance of the product and contents of the pack

Zeldox 40 mg hard capsules are presented as hard gelatin capsules. The capsules are blue, marked with “VTRS” and “ZDX 40”.

Pack sizes:

Aluminum PVC/PVA blisters containing 14, 20, 30, 50, 56, 60 or 100 capsules.

Only certain pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland

Manufacturer:

MEDIS INTERNATIONAL a.s., výrobní závod Bolatice
Prumyslová 961/16
747 23 Bolatice
Czech Republic

or

Pfizer Manufacturing Deutschland GmbH
Mooswaldallee 1
79108 Freiburg im Breisgau
Germany

Further information on this medicinal product is available from the local representative of the Marketing Authorization Holder:

Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Date of the most recent review of this leaflet: October 2022

“Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/”